These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 36050264)

  • 1. Nomograms Combining Clinical and Imaging Parameters to Predict Recurrence and Disease-free Survival After Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
    Zhang Y; Liu L; Zhang K; Su R; Jia H; Qian L; Dong J
    Acad Radiol; 2023 Mar; 30(3):499-508. PubMed ID: 36050264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IVIM-DWI and MRI-based radiomics in cervical cancer: Prediction of concurrent chemoradiotherapy sensitivity in combination with clinical prognostic factors.
    Zhang Y; Zhang K; Jia H; Xia B; Zang C; Liu Y; Qian L; Dong J
    Magn Reson Imaging; 2022 Sep; 91():37-44. PubMed ID: 35568271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive assessment of postoperative recurrence and survival in patients with cervical cancer.
    Zhang Y; Zou J; Li L; Han M; Dong J; Wang X
    Eur J Surg Oncol; 2024 Oct; 50(10):108583. PubMed ID: 39116515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning-based radiomics for predicting outcomes in cervical cancer patients undergoing concurrent chemoradiotherapy.
    Xin W; Rixin S; Linrui L; Zhihui Q; Long L; Yu Z
    Comput Biol Med; 2024 Jul; 177():108593. PubMed ID: 38801795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric magnetic resonance imaging-derived radiomics for the prediction of disease-free survival in early-stage squamous cervical cancer.
    Zhou Y; Gu HL; Zhang XL; Tian ZF; Xu XQ; Tang WW
    Eur Radiol; 2022 Apr; 32(4):2540-2551. PubMed ID: 34642807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or concurrent chemoradiotherapy alone.
    Wei G; Jiang P; Tang Z; Qu A; Deng X; Guo F; Sun H; Zhang Y; Gu L; Zhang S; Mu W; Wang J; Tian J
    Magn Reson Imaging; 2022 Sep; 91():81-90. PubMed ID: 35636572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of outcome using pretreatment
    Lucia F; Visvikis D; Desseroit MC; Miranda O; Malhaire JP; Robin P; Pradier O; Hatt M; Schick U
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):768-786. PubMed ID: 29222685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomograms combining computed tomography-based body composition changes with clinical prognostic factors to predict survival in locally advanced cervical cancer patients.
    Fu B; Wei L; Wang C; Xiong B; Bo J; Jiang X; Zhang Y; Jia H; Dong J
    J Xray Sci Technol; 2024; 32(2):427-441. PubMed ID: 38189735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine Learning-Based Models for Assessing Postoperative Risk Factors in Patients with Cervical Cancer.
    Yu Z; Zhihui Q; Linrui L; Long L; Qibing W
    Acad Radiol; 2024 Apr; 31(4):1410-1418. PubMed ID: 37891091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
    Zhang X; Zhao J; Zhang Q; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
    Cancer Imaging; 2022 Jul; 22(1):35. PubMed ID: 35842679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer.
    Gao S; Du S; Lu Z; Xin J; Gao S; Sun H
    Eur Radiol; 2020 Feb; 30(2):1191-1201. PubMed ID: 31493211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining Intravoxel Incoherent Motion Diffusion Weighted Imaging and Texture Analysis for a Nomogram to Predict Early Treatment Response to Concurrent Chemoradiotherapy in Cervical Cancer Patients.
    Zheng X; Li C; Zhang L; Cao F; Fang X; Qian L; Dong J
    J Oncol; 2021; 2021():9345353. PubMed ID: 34976060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An MRI-based radiomics signature and clinical characteristics for survival prediction in early-stage cervical cancer.
    Zheng RR; Cai MT; Lan L; Huang XW; Yang YJ; Powell M; Lin F
    Br J Radiol; 2022 Jan; 95(1129):20210838. PubMed ID: 34797703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.
    Zheng X; Guo W; Dong J; Qian L
    Magn Reson Imaging; 2020 Oct; 72():159-166. PubMed ID: 32621877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of disease progression following concurrent chemoradiotherapy for uterine cervical cancer: value of post-treatment diffusion-weighted imaging.
    Park JJ; Kim CK; Park BK
    Eur Radiol; 2016 Sep; 26(9):3272-9. PubMed ID: 26685853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
    Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy.
    Zhang Q; Guo J; Ouyang H; Chen S; Zhao X; Yu X
    Eur Radiol; 2022 Apr; 32(4):2529-2539. PubMed ID: 34647177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy.
    Zhao B; Cao K; Li XT; Zhu HT; Sun YS
    BMC Cancer; 2019 Nov; 19(1):1115. PubMed ID: 31729974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.
    Hua L; Wei M; Feng C; Li S; Wen X; Chen S
    Cancer Biother Radiopharm; 2024 Nov; 39(9):690-705. PubMed ID: 38828494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.